Hypothesis: Silver nanoparticles as an adjuvant for cancertherapy

Advanced Pharmaceutical Bulletin

Volumn 2, Issue 1, 2012, Pages 133-

  Mohammadzadeh, Ramin ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Cancertherapy; Micelle; Nanoparticles

Indexed keywords

COPOLYMER; CYTOCHROME C; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE; SUPEROXIDE DISMUTASE; THIOREDOXIN; THIOREDOXIN PEROXIDASE;

ADJUVANT CHEMOTHERAPY; APOPTOSIS; ARTICLE; CANCER CELL; DRUG RELEASE; DRUG SOLUBILITY; MICELLE;

EID: 84872686967     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2012.020     Document Type: Article

References (3)

1. Chen X, Schluesener HJ. Nanosilver: A nanoproduct in medical application. Toxicology Letters 2008; 176:1-12
2. Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E, Domann E, Schnettler R. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004; 25:4383-4391.
3. Bae Y, Jang WD, Nishiyama N, Fukushima S, Kataoka K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol Biosyst 2005; 1:242-250.